← FDA Drug Approvals (Drugs@FDA)
THALIDOMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2023-04-27
Drug application
- FDA Application #
ANDA213267- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- THALIDOMIDE
- Generic name
- Thalidomide
- Active ingredients
- THALIDOMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NATCO
- First approval
- 2023-04-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown